Labcorp Holdings (LH) Current Deferred Revenue (2015 - 2026)

Labcorp Holdings (LH) has 12 years of Current Deferred Revenue data on file, last reported at $405.2 million in Q1 2026.

• Quarterly Current Deferred Revenue rose 4.35% year-over-year to $405.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $405.2 million (up 4.35% YoY) and the FY2025 annual result came in at $439.1 million, up 11.96% from the prior year.
• Current Deferred Revenue eased to $405.2 million in Q1 2026 per LH's latest filing, from $439.1 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $586.7 million in Q1 2023, with the low at $310.6 million in Q4 2022.
• Average Current Deferred Revenue over 5 years is $426.1 million, with a median of $398.0 million recorded in 2025.
• Year-over-year, Current Deferred Revenue slumped 44.39% in 2022 and jumped 35.77% in 2023.
• Labcorp Holdings' Current Deferred Revenue stood at $310.6 million in 2022, then jumped by 35.77% to $421.7 million in 2023, then decreased by 7.0% to $392.2 million in 2024, then increased by 11.96% to $439.1 million in 2025, then decreased by 7.72% to $405.2 million in 2026.
• Business Quant data shows LH's Current Deferred Revenue at $405.2 million in Q1 2026, $439.1 million in Q4 2025, and $391.6 million in Q3 2025.